id	sid	eid	entity	type
dpc-3114	2	1	2023;13(4):e2023215 1	CARDINAL
dpc-3114	2	2	tildrakizumab	PERSON
dpc-3114	2	3	italian	NORP
dpc-3114	2	4	eugenia veronica di brizzi1	PERSON
dpc-3114	2	5	pierfrancesco benvenuto1	ORG
dpc-3114	2	6	giuseppe argenziano1	PERSON
dpc-3114	2	7	rocco de pasquale2	PERSON
dpc-3114	2	8	silvia fiorella3	PERSON
dpc-3114	2	9	claudia giofrè4	PERSON
dpc-3114	2	10	maria letizia musumeci2	PERSON
dpc-3114	2	11	giovanni palazzo5	PERSON
dpc-3114	2	12	zichichi6	GPE
dpc-3114	2	13	balato1 1	LAW
dpc-3114	2	14	university of campania	ORG
dpc-3114	2	15	luigi vanvitelli	PERSON
dpc-3114	2	16	naples	GPE
dpc-3114	2	17	italy 2	FAC
dpc-3114	2	18	g. rodolico-s. marco	PERSON
dpc-3114	2	19	catania	GPE
dpc-3114	2	20	3	CARDINAL
dpc-3114	2	21	raffaele dimiccoli	PERSON
dpc-3114	2	22	barletta	GPE
dpc-3114	2	23	italy 4	FAC
dpc-3114	2	24	messina	GPE
dpc-3114	2	25	italy 5	ORG
dpc-3114	2	26	italy 6	FAC
dpc-3114	2	27	s. antonio	PERSON
dpc-3114	2	28	trapani	PERSON
dpc-3114	2	29	italy	GPE
dpc-3114	2	30	tildrakizumab	PERSON
dpc-3114	2	31	di brizzi ev	PERSON
dpc-3114	2	32	benvenuto p	GPE
dpc-3114	2	33	tildrakizumab	PERSON
dpc-3114	2	34	italian	NORP
dpc-3114	4	1	2023;13(4):e2023215	CARDINAL
dpc-3114	4	2	april 21	DATE
dpc-3114	4	3	2023	CARDINAL
dpc-3114	5	1	october 2023	DATE
dpc-3114	5	2	2023	CARDINAL
dpc-3114	6	1	https://creativecommons.org/licenses/by-nc/4.0/	ORG
dpc-3114	10	1	eugenia veronica di brizzi	PERSON
dpc-3114	10	2	md	GPE
dpc-3114	10	3	university of campania luigi vanvitelli	ORG
dpc-3114	10	4	nuovo policlinico	PERSON
dpc-3114	10	5	edificio 9c	DATE
dpc-3114	10	6	5	CARDINAL
dpc-3114	10	7	80131	DATE
dpc-3114	10	8	italy	GPE
dpc-3114	11	1	tildrakizumab	PERSON
dpc-3114	11	2	2018	DATE
dpc-3114	12	1	48 weeks	DATE
dpc-3114	14	1	bsa	ORG
dpc-3114	14	2	12 and 48 weeks	DATE
dpc-3114	16	1	51	CARDINAL
dpc-3114	17	1	19.2 ± 8.5	MONEY
dpc-3114	17	2	bsa	ORG
dpc-3114	17	3	16 ± 10.4	QUANTITY
dpc-3114	17	4	2	CARDINAL
dpc-3114	18	1	2023;13(4):e2023215	CARDINAL
dpc-3114	18	2	1	CARDINAL
dpc-3114	19	1	tildrakizumab	PERSON
dpc-3114	19	2	2018	DATE
dpc-3114	19	3	2	CARDINAL
dpc-3114	20	1	firstly	ORDINAL
dpc-3114	20	2	2b	CARDINAL
dpc-3114	20	3	two	CARDINAL
dpc-3114	20	4	3	CARDINAL
dpc-3114	20	5	1 and	CARDINAL
dpc-3114	20	6	2	CARDINAL
dpc-3114	20	7	2	CARDINAL
dpc-3114	21	1	tildrakizumab	PERSON
dpc-3114	21	2	3,4	CARDINAL
dpc-3114	22	1	5	CARDINAL
dpc-3114	23	1	tildrakizumab	PERSON
dpc-3114	23	2	11,12	CARDINAL
dpc-3114	24	1	48 weeks	DATE
dpc-3114	25	1	seven	CARDINAL
dpc-3114	25	2	italian	NORP
dpc-3114	27	1	age ≥ 18 years	DATE
dpc-3114	27	2	10	CARDINAL
dpc-3114	28	1	50	CARDINAL
dpc-3114	29	1	at least 4 weeks	DATE
dpc-3114	30	1	the last 5 years	DATE
dpc-3114	31	1	tildrakizumab	PERSON
dpc-3114	31	2	100 mg	QUANTITY
dpc-3114	31	3	weeks 0	DATE
dpc-3114	31	4	4	DATE
dpc-3114	31	5	every 12 weeks	DATE
dpc-3114	33	1	bsa	ORG
dpc-3114	33	2	12 and 48 weeks	DATE
dpc-3114	34	1	tildrakizumab	PERSON
dpc-3114	34	2	75%	PERCENT
dpc-3114	34	3	90%	PERCENT
dpc-3114	34	4	100%	PERCENT
dpc-3114	34	5	75	CARDINAL
dpc-3114	34	6	90	CARDINAL
dpc-3114	34	7	100	CARDINAL
dpc-3114	34	8	12 and 48 weeks	DATE
dpc-3114	35	1	weeks 12	DATE
dpc-3114	35	2	48	DATE
dpc-3114	36	1	aes	ORG
dpc-3114	36	2	aes	ORG
dpc-3114	37	1	aes	ORG
dpc-3114	37	2	weeks 12 and	DATE
dpc-3114	37	3	48	DATE
dpc-3114	38	1	aes	ORG
dpc-3114	38	2	18.2 ± 6.8	MONEY
dpc-3114	39	1	12 weeks	DATE
dpc-3114	39	2	3.5 ± 2.7	DATE
dpc-3114	39	3	0.001	CARDINAL
dpc-3114	39	4	week 48	DATE
dpc-3114	39	5	0.6 ± 1.5	MONEY
dpc-3114	39	6	0.001	CARDINAL
dpc-3114	40	1	week 12	DATE
dpc-3114	40	2	bsa	ORG
dpc-3114	40	3	0.001	CARDINAL
dpc-3114	40	4	week 48	DATE
dpc-3114	41	1	week 12	DATE
dpc-3114	41	2	week 48	DATE
dpc-3114	41	3	0.001	CARDINAL
dpc-3114	42	1	tildrakizumab	PERSON
dpc-3114	42	2	daily	DATE
dpc-3114	44	1	2023;13(4):e2023215	CARDINAL
dpc-3114	44	2	3	CARDINAL
dpc-3114	45	1	±	CARDINAL
dpc-3114	47	1	anti-il17	NORP
dpc-3114	47	2	anti-il12/23	NORP
dpc-3114	47	3	bsa	ORG
dpc-3114	48	1	less than 0.05	CARDINAL
dpc-3114	49	1	6.0	CARDINAL
dpc-3114	49	2	graphpad software inc.	ORG
dpc-3114	49	3	sas®	ORG
dpc-3114	49	4	9.3	CARDINAL
dpc-3114	49	5	sas institute inc.	ORG
dpc-3114	50	1	51	CARDINAL
dpc-3114	50	2	76.5%	PERCENT
dpc-3114	50	3	39/51	CARDINAL
dpc-3114	50	4	52.3 ±	CARDINAL
dpc-3114	50	5	14.7 years	DATE
dpc-3114	50	6	1	CARDINAL
dpc-3114	51	1	19.2 ± 8.5	MONEY
dpc-3114	51	2	bsa	ORG
dpc-3114	51	3	16 ± 10.4	QUANTITY
dpc-3114	51	4	18.2 ± 6.8	MONEY
dpc-3114	52	1	29.8 ± 11.9 kg/m2	QUANTITY
dpc-3114	52	2	27.5%	PERCENT
dpc-3114	52	3	14/51	CARDINAL
dpc-3114	52	4	30	CARDINAL
dpc-3114	53	1	66.7%	PERCENT
dpc-3114	53	2	34/51	CARDINAL
dpc-3114	54	1	17.6%	PERCENT
dpc-3114	54	2	9/51	CARDINAL
dpc-3114	54	3	10.4 ± 9.7	CARDINAL
dpc-3114	54	4	28	CARDINAL
dpc-3114	54	5	4.9 ± 5.2	CARDINAL
dpc-3114	57	1	at least 1	CARDINAL
dpc-3114	58	1	54.9%	PERCENT
dpc-3114	58	2	28/51	CARDINAL
dpc-3114	58	3	at least 2	CARDINAL
dpc-3114	59	1	44/51	CARDINAL
dpc-3114	59	2	86.3%	PERCENT
dpc-3114	59	3	1	CARDINAL
dpc-3114	60	1	tildrakizumab	PERSON
dpc-3114	60	2	47%	PERCENT
dpc-3114	60	3	anti-tnf	PRODUCT
dpc-3114	60	4	24/51	CARDINAL
dpc-3114	60	5	31.4%	PERCENT
dpc-3114	60	6	16/51	CARDINAL
dpc-3114	60	7	21.6%	PERCENT
dpc-3114	60	8	11/51	CARDINAL
dpc-3114	61	1	5.8%	PERCENT
dpc-3114	61	2	3/51	CARDINAL
dpc-3114	61	3	1/3	CARDINAL
dpc-3114	61	4	week 12	DATE
dpc-3114	61	5	1/6	CARDINAL
dpc-3114	61	6	week 48	DATE
dpc-3114	61	7	1/6	CARDINAL
dpc-3114	61	8	week 48	DATE
dpc-3114	63	1	1	CARDINAL
dpc-3114	65	1	±	CARDINAL
dpc-3114	65	2	39	CARDINAL
dpc-3114	65	3	76.5	CARDINAL
dpc-3114	65	4	age (years	DATE
dpc-3114	65	5	52.3±	CARDINAL
dpc-3114	65	6	14.7	CARDINAL
dpc-3114	65	7	16.9 bmi	QUANTITY
dpc-3114	65	8	29.8±	CARDINAL
dpc-3114	65	9	11.9	CARDINAL
dpc-3114	65	10	30 14	DATE
dpc-3114	65	11	27.5	CARDINAL
dpc-3114	65	12	12	CARDINAL
dpc-3114	65	13	23.5	CARDINAL
dpc-3114	65	14	19	DATE
dpc-3114	65	15	37.3	CARDINAL
dpc-3114	65	16	15	CARDINAL
dpc-3114	65	17	29.4	CARDINAL
dpc-3114	65	18	8	CARDINAL
dpc-3114	65	19	15.7	CARDINAL
dpc-3114	65	20	34	CARDINAL
dpc-3114	65	21	66.7	CARDINAL
dpc-3114	65	22	8	CARDINAL
dpc-3114	65	23	15.7	CARDINAL
dpc-3114	65	24	17	CARDINAL
dpc-3114	65	25	33.3	CARDINAL
dpc-3114	65	26	24	CARDINAL
dpc-3114	65	27	47.1	CARDINAL
dpc-3114	65	28	11	CARDINAL
dpc-3114	65	29	21.6	CARDINAL
dpc-3114	65	30	9	CARDINAL
dpc-3114	65	31	17.6	CARDINAL
dpc-3114	65	32	53.2±	CARDINAL
dpc-3114	65	33	11.4	CARDINAL
dpc-3114	65	34	10.4± 9.7	CARDINAL
dpc-3114	65	35	22.9±	CARDINAL
dpc-3114	65	36	10.3	CARDINAL
dpc-3114	65	37	21.7±	CARDINAL
dpc-3114	65	38	10.9	CARDINAL
dpc-3114	65	39	8.5	CARDINAL
dpc-3114	65	40	bsa	ORG
dpc-3114	65	41	16± 10.4	CARDINAL
dpc-3114	65	42	6.8	CARDINAL
dpc-3114	65	43	acitretin anti-tnf	PERSON
dpc-3114	65	44	anti-il23	NORP
dpc-3114	65	45	1	CARDINAL
dpc-3114	65	46	2	CARDINAL
dpc-3114	65	47	28	CARDINAL
dpc-3114	65	48	18 11	CARDINAL
dpc-3114	65	49	23 28	CARDINAL
dpc-3114	65	50	bsa	ORG
dpc-3114	66	1	aes	ORG
dpc-3114	67	1	aes	ORG
dpc-3114	67	2	3.9%	PERCENT
dpc-3114	67	3	2/51	CARDINAL
dpc-3114	67	4	4	CARDINAL
dpc-3114	68	1	2023;13(4):e2023215	CARDINAL
dpc-3114	69	1	week 12	DATE
dpc-3114	69	2	3	CARDINAL
dpc-3114	69	3	anti-il17	NORP
dpc-3114	69	4	anti-il12/23	NORP
dpc-3114	69	5	0.001	CARDINAL
dpc-3114	70	1	week 48	DATE
dpc-3114	71	1	bsa	ORG
dpc-3114	71	2	0.001	CARDINAL
dpc-3114	72	1	week 12	DATE
dpc-3114	72	2	bsa	ORG
dpc-3114	72	3	0.001	CARDINAL
dpc-3114	72	4	week 48	DATE
dpc-3114	73	1	week 12	DATE
dpc-3114	73	2	week 48	DATE
dpc-3114	73	3	0.001	CARDINAL
dpc-3114	74	1	3	CARDINAL
dpc-3114	75	1	tildrakizumab	PERSON
dpc-3114	75	2	5	CARDINAL
dpc-3114	76	1	the day	DATE
dpc-3114	77	1	19.2 ± 8.5	MONEY
dpc-3114	77	2	12 weeks	DATE
dpc-3114	77	3	3.5 ± 2.7	DATE
dpc-3114	77	4	0.001	CARDINAL
dpc-3114	77	5	week 48	DATE
dpc-3114	77	6	0.6 ± 1.5	MONEY
dpc-3114	77	7	0.001	CARDINAL
dpc-3114	78	1	bsa	ORG
dpc-3114	78	2	1	CARDINAL
dpc-3114	79	1	absolute pasi	PERSON
dpc-3114	79	2	43%	PERCENT
dpc-3114	79	3	90%	PERCENT
dpc-3114	79	4	week 12	DATE
dpc-3114	80	1	weeks 48	DATE
dpc-3114	81	1	2	CARDINAL
dpc-3114	81	2	67%	PERCENT
dpc-3114	81	3	30% and 22%	PERCENT
dpc-3114	81	4	75	CARDINAL
dpc-3114	81	5	90	CARDINAL
dpc-3114	81	6	100	CARDINAL
dpc-3114	81	7	week 12	DATE
dpc-3114	82	1	48	DATE
dpc-3114	83	1	3	CARDINAL
dpc-3114	84	1	2	CARDINAL
dpc-3114	84	2	anti-il17	NORP
dpc-3114	84	3	1	CARDINAL
dpc-3114	85	1	bsa	ORG
dpc-3114	86	1	2	CARDINAL
dpc-3114	87	1	5	CARDINAL
dpc-3114	87	2	12 and 48 weeks	DATE
dpc-3114	89	1	≤5	PRODUCT
dpc-3114	89	2	5 12	PERCENT
dpc-3114	89	3	43	CARDINAL
dpc-3114	89	4	46	DATE
dpc-3114	89	5	90	CARDINAL
dpc-3114	89	6	5	CARDINAL
dpc-3114	89	7	10	CARDINAL
dpc-3114	89	8	90	CARDINAL
dpc-3114	89	9	48	DATE
dpc-3114	89	10	94	CARDINAL
dpc-3114	89	11	3	CARDINAL
dpc-3114	89	12	6	CARDINAL
dpc-3114	90	1	3	CARDINAL
dpc-3114	91	1	75	CARDINAL
dpc-3114	91	2	75	CARDINAL
dpc-3114	91	3	90	CARDINAL
dpc-3114	91	4	100	CARDINAL
dpc-3114	91	5	12 and 48 weeks	DATE
dpc-3114	94	1	75	CARDINAL
dpc-3114	94	2	100	CARDINAL
dpc-3114	94	3	33	CARDINAL
dpc-3114	94	4	34	DATE
dpc-3114	94	5	67	CARDINAL
dpc-3114	94	6	15	CARDINAL
dpc-3114	94	7	11	DATE
dpc-3114	94	8	22	CARDINAL
dpc-3114	94	9	48	CARDINAL
dpc-3114	94	10	10	CARDINAL
dpc-3114	94	11	46	DATE
dpc-3114	94	12	90	CARDINAL
dpc-3114	94	13	35	DATE
dpc-3114	94	14	68	CARDINAL
dpc-3114	94	15	32	DATE
dpc-3114	96	1	2023;13(4):e2023215	CARDINAL
dpc-3114	97	1	2	CARDINAL
dpc-3114	97	2	two	CARDINAL
dpc-3114	97	3	3	CARDINAL
dpc-3114	97	4	2217	CARDINAL
dpc-3114	97	5	15	CARDINAL
dpc-3114	98	1	197	CARDINAL
dpc-3114	98	2	52.3%	PERCENT
dpc-3114	98	3	127 guselkumab	QUANTITY
dpc-3114	98	4	55	CARDINAL
dpc-3114	98	5	15	CARDINAL
dpc-3114	98	6	at least 3 months	DATE
dpc-3114	98	7	austria	GPE
dpc-3114	101	1	16	CARDINAL
dpc-3114	102	1	17	CARDINAL
dpc-3114	103	1	tildrakizumab	PERSON
dpc-3114	104	1	3.9%	PERCENT
dpc-3114	105	1	3-10,13-16	CARDINAL
dpc-3114	106	1	firstly	ORDINAL
dpc-3114	108	1	tildrakizumab	PERSON
dpc-3114	108	2	daily	DATE
dpc-3114	113	1	2	CARDINAL
dpc-3114	114	1	bsa	ORG
dpc-3114	114	2	anti-il17	NORP
dpc-3114	114	3	anti-il12/23	NORP
dpc-3114	115	1	19.2	CARDINAL
dpc-3114	115	2	week 48	DATE
dpc-3114	115	3	0.6	CARDINAL
dpc-3114	115	4	75	CARDINAL
dpc-3114	115	5	90	DATE
dpc-3114	115	6	100	CARDINAL
dpc-3114	116	1	bsa	ORG
dpc-3114	118	1	30	CARDINAL
dpc-3114	118	2	12-month	DATE
dpc-3114	118	3	16 to 1.5	CARDINAL
dpc-3114	118	4	13	CARDINAL
dpc-3114	119	1	59	CARDINAL
dpc-3114	119	2	tildrakizumab	PERSON
dpc-3114	119	3	28 weeks	DATE
dpc-3114	119	4	80%	PERCENT
dpc-3114	120	1	28 weeks	DATE
dpc-3114	120	2	68%	PERCENT
dpc-3114	120	3	bio-naïve	PERSON
dpc-3114	120	4	60%	PERCENT
dpc-3114	120	5	8	CARDINAL
dpc-3114	121	1	italian	NORP
dpc-3114	121	2	237	CARDINAL
dpc-3114	121	3	10	CARDINAL
dpc-3114	122	1	week 52	DATE
dpc-3114	122	2	90.91%	PERCENT
dpc-3114	122	3	73.55%	PERCENT
dpc-3114	122	4	58.68%	PERCENT
dpc-3114	122	5	75	CARDINAL
dpc-3114	122	6	90	CARDINAL
dpc-3114	122	7	100	CARDINAL
dpc-3114	123	1	85.95%	PERCENT
dpc-3114	123	2	week 52	DATE
dpc-3114	124	1	14	CARDINAL
dpc-3114	125	1	75/90/100	CARDINAL
dpc-3114	126	1	6	CARDINAL
dpc-3114	127	1	2023;13(4):e2023215	CARDINAL
dpc-3114	128	1	simpson k	PERSON
dpc-3114	128	2	zm	ORG
dpc-3114	128	3	howard a	PERSON
dpc-3114	129	1	tildrakizumab	PERSON
dpc-3114	130	1	australas j	PERSON
dpc-3114	130	2	2021;62(3):390–393	CARDINAL
dpc-3114	131	1	10.1111	CARDINAL
dpc-3114	132	1	34114645	CARDINAL
dpc-3114	133	1	10	CARDINAL
dpc-3114	134	1	galluzzo m	PERSON
dpc-3114	135	1	j clin med	PERSON
dpc-3114	136	1	10.3390	CARDINAL
dpc-3114	137	1	35566756	DATE
dpc-3114	139	1	11	CARDINAL
dpc-3114	140	1	conti	ORG
dpc-3114	141	1	secukinumab	GPE
dpc-3114	143	1	2019;180(6):1547-1548	CARDINAL
dpc-3114	144	1	10.1111/bjd.17580	MONEY
dpc-3114	145	1	30578668	CARDINAL
dpc-3114	146	1	12	CARDINAL
dpc-3114	147	1	t, puig l	ORG
dpc-3114	147	2	il)-17	ORG
dpc-3114	148	1	j clin	PERSON
dpc-3114	149	1	2022;23(6):891-904	CARDINAL
dpc-3114	150	1	10.1007	CARDINAL
dpc-3114	150	2	35976568	CARDINAL
dpc-3114	152	1	wei nw	PERSON
dpc-3114	152	2	chi s	PERSON
dpc-3114	152	3	lebwohl mg	PERSON
dpc-3114	153	1	tildrakizumab	PERSON
dpc-3114	155	1	2022;7(2):55–9	CARDINAL
dpc-3114	156	1	5 10.1177/24755303221077211	CARDINAL
dpc-3114	157	1	14	CARDINAL
dpc-3114	157	2	narcisi	PERSON
dpc-3114	157	3	valenti m	PERSON
dpc-3114	158	1	52-week	DATE
dpc-3114	158	2	italian	NORP
dpc-3114	160	1	2023;37(1):93-103	DATE
dpc-3114	161	1	10.1111/jdv.18594	MONEY
dpc-3114	162	1	36156312	DATE
dpc-3114	164	1	15	CARDINAL
dpc-3114	165	1	poulin y	PERSON
dpc-3114	165	2	2b	CARDINAL
dpc-3114	165	3	2	CARDINAL
dpc-3114	165	4	3	CARDINAL
dpc-3114	167	1	2020;34(7	CARDINAL
dpc-3114	167	2	1500–1509	DATE
dpc-3114	168	1	10.1111	CARDINAL
dpc-3114	169	1	16	CARDINAL
dpc-3114	170	1	graier1	PERSON
dpc-3114	170	2	weger w	ORG
dpc-3114	170	3	jonak	PERSON
dpc-3114	171	1	23	CARDINAL
dpc-3114	171	2	austrian	NORP
dpc-3114	172	1	sci rep	ORG
dpc-3114	172	2	2022;12(1):15078	CARDINAL
dpc-3114	173	1	10.1038	CARDINAL
dpc-3114	174	1	36064563	CARDINAL
dpc-3114	176	1	1	CARDINAL
dpc-3114	177	1	ghoreschi k	PERSON
dpc-3114	177	2	enerbäck	ORG
dpc-3114	177	3	r.	NORP
dpc-3114	178	1	lancet	ORG
dpc-3114	179	1	2021	CARDINAL
dpc-3114	179	2	397(10275):754-766	CARDINAL
dpc-3114	180	1	10.1016	CARDINAL
dpc-3114	181	1	33515492	CARDINAL
dpc-3114	182	1	2	CARDINAL
dpc-3114	182	2	markham a. tildrakizumab	PERSON
dpc-3114	182	3	first	ORDINAL
dpc-3114	184	1	2018;78(8):845–849	CARDINAL
dpc-3114	184	2	10.1007	CARDINAL
dpc-3114	185	1	29752706	CARDINAL
dpc-3114	186	1	3	CARDINAL
dpc-3114	186	2	papp k	PERSON
dpc-3114	186	3	reich k	PERSON
dpc-3114	186	4	tildrakizumab	PERSON
dpc-3114	186	5	iib	PRODUCT
dpc-3114	188	1	2015;173(4):930–939	CARDINAL
dpc-3114	188	2	10.1111	CARDINAL
dpc-3114	189	1	pmid	PERSON
dpc-3114	189	2	26042589	DATE
dpc-3114	190	1	4	CARDINAL
dpc-3114	190	2	reich k	PERSON
dpc-3114	190	3	papp ka	PERSON
dpc-3114	190	4	tildrakizumab	PERSON
dpc-3114	190	5	1	CARDINAL
dpc-3114	190	6	2	CARDINAL
dpc-3114	190	7	two	CARDINAL
dpc-3114	190	8	3	CARDINAL
dpc-3114	191	1	lancet	ORG
dpc-3114	192	1	2017;390(10091):276	CARDINAL
dpc-3114	193	1	10.1016	CARDINAL
dpc-3114	193	2	6736(17)31279-5	CARDINAL
dpc-3114	194	1	28596043	DATE
dpc-3114	195	1	5	CARDINAL
dpc-3114	195	2	castelli	PERSON
dpc-3114	195	3	a.	PERSON
dpc-3114	195	4	tildrakizumab	PERSON
dpc-3114	197	1	2021;10:2021	CARDINAL
dpc-3114	197	2	10.7573	CARDINAL
dpc-3114	198	1	34104197	DATE
dpc-3114	200	1	6	CARDINAL
dpc-3114	200	2	rodriguez-fernandez freire l	PERSON
dpc-3114	200	3	r. tildrakizumab	PERSON
dpc-3114	202	1	2022;61(9):e355	CARDINAL
dpc-3114	202	2	10.1111/ijd.15840	MONEY
dpc-3114	203	1	34632570	CARDINAL
dpc-3114	204	1	7	CARDINAL
dpc-3114	204	2	drerup ka	PERSON
dpc-3114	204	3	gerdes s	PERSON
dpc-3114	206	1	2022;238(4):615-619	CARDINAL
dpc-3114	207	1	10.1159/000519924	CARDINAL
dpc-3114	208	1	34775387	DATE
dpc-3114	210	1	8	CARDINAL
dpc-3114	210	2	caldarola	ORG
dpc-3114	210	3	galluzzo m	PERSON
dpc-3114	210	4	tildrakizumab	PERSON
dpc-3114	212	1	2022;35(6):e15488	CARDINAL
dpc-3114	212	2	10.1111/dth.15488	CARDINAL